SQuID

Incomplete

Griffey RT, et al. "The SQuID protocol (subcutaneous insulin in diabetic ketoacidosis): Impacts on ED operational metrics". Acad Emerg Med. 2023. 30:800-808.
PubMed

Guidelines

As of June 2018, no guidelines have been published that reflect the results of this trial.

Design

• Multicenter, double-blind, parallel-group, randomized, controlled trial
• N=
  • Intervention (n=)
  • Placebo (n=)
• Setting:
• Enrollment:
• Mean follow-up:
• Analysis:
• Primary Outcome:

Population

Baseline Characteristics

BLANK Group displayed

• Demographics:
• Physiologic parameters:
• Anthropomorphics: Weight
• Labs:
• Site of infection

Outcomes

Comparisons are BLANK therapy vs. BLANK therapy.